Increased extracellular volume in the liver of pediatric Fontan patients
Charlotte de Lange1,2, Marjolein J E Reichert1, Joseph J Pagano3
1Department of Pediatrics, Division of Cardiology, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
Insights
Pediatric patients with single ventricle conditions show elevated liver fibrosis markers, including native T1 and extracellular volume fraction (ECV), detected via cardiovascular magnetic resonance (CMR). These changes suggest liver fibrosis or congestion, even in young patients.
Area of Science:
- Cardiovascular Imaging
- Pediatric Cardiology
- Hepatology
Background:
- Single ventricle physiology places patients at high risk for liver fibrosis.
- The prevalence and extent of liver fibrosis in children with bidirectional cavopulmonary connection (BCPC) and Fontan circulation are not well-established.
- Cardiovascular magnetic resonance (CMR) T1 relaxometry and extracellular volume fraction (ECV) can indicate liver fibrotic remodeling and congestion.
Purpose of the Study:
- To investigate elevated native T1 and ECV in pediatric patients with single ventricle physiology.
- To assess these as potential markers for liver fibrosis and/or congestion.
Main Methods:
- Retrospective analysis of hepatic native T1 times and ECV using cardiac MRI.
- Comparison between children with BCPC and Fontan circulations and healthy pediatric controls.
Main Results:
- Fontan patients exhibited higher native T1 times compared to BCPC patients and controls (p < 0.001).
- ECV was significantly higher in Fontan patients (41.4%) than BCPC patients (36.4%, p=0.02).
- In Fontan patients, T1 correlated with cardiopulmonary bypass time and ventricular volumes, and inversely with oxygen saturation and body surface area.
Conclusions:
- Patients with Fontan and BCPC circulations demonstrate elevated CMR-derived markers indicative of hepatic fibrosis and/or congestion.
- These liver tissue changes are detectable even in young patients.
- Central venous pressure was not associated with these observed T1 or ECV changes.
Background:
Patients with single ventricle physiology are at increased risk for developing liver fibrosis. Its extent and prevalence in children with bidirectional cavopulmonary connection (BCPC) and Fontan circulation are unclear. Extracellular volume fraction (ECV), derived from cardiovascular magnetic resonance (CMR) and T1 relaxometry, reflect fibrotic remodeling and/or congestion in the liver. The aim of this study was to investigate whether pediatric patients with single ventricle physiology experience increased native T1 and ECV as markers of liver fibrosis/congestion.
Methods:
Hepatic native T1 times and ECV, using a cardiac short axis modified Look-Locker inversion recovery sequence displaying the liver, were measured retrospectively in children with BCPC- and Fontan circulations and compared to pediatric controls.
Results:
Hepatic native T1 time were increased in Fontan patients (n = 62, 11.4 ± 4.4 years, T1 762 ± 64 ms) versus BCPC patients (n = 20, 2.8 ± 0.9 years, T1 645 ± 43 ms, p = 0.04). Both cohorts had higher T1 than controls (n = 44, 13.7 ± 2.9 years, T1 604 ± 54 ms, p < 0.001 for both). ECV was 41.4 ± 4.8% in Fontan and 36.4 ± 4.8% in BCPC patients, respectively (p = 0.02). In Fontan patients, T1 values correlated with exposure to cardiopulmonary bypass time (R = 0.3, p = 0.02), systolic and end diastolic volumes (R = 0.3, p = 0.04 for both) and inversely with oxygen saturations and body surface area (R = -0.3, p = 0.04 for both). There were no demonstrable associations of T1 or ECV with central venous pressure or age after Fontan.
Conclusion:
Fontan and BCPC patients have elevated CMR markers suggestive of hepatic fibrosis and/or congestion, even at a young age. The tissue changes do not appear to be related to central venous pressures.
Trial Registration:
Retrospectively registered data.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Increased Body Temperature
Increased pulse rate
Many factors can elevate the risk of developing tachycardia. These include advanced age, a family history of arrhythmias, and an...


